Prostate cancer cells express several immunogenic antigens that are specific to the prostate, including prostatic acid phosphatase (PAP) and prostate-specific antigen (PSA), both of which have been explored as targets for antigen-based vaccines [9]. The gene discussed is ACP3; the disease is prostate carcinoma.